Literature DB >> 8795471

K+ channel opening: a new drug principle in cardiovascular medicine.

J E Nielsen-Kudsk1, S Boesgaard, J Aldershvile.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8795471      PMCID: PMC484456          DOI: 10.1136/hrt.76.2.109

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  45 in total

1.  Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels.

Authors:  J Daut; W Maier-Rudolph; N von Beckerath; G Mehrke; K Günther; L Goedel-Meinen
Journal:  Science       Date:  1990-03-16       Impact factor: 47.728

2.  Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes.

Authors:  G E Kirsch; J Codina; L Birnbaumer; A M Brown
Journal:  Am J Physiol       Date:  1990-09

Review 3.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

4.  Acute haemodynamic effects of cromakalim in patients with angina pectoris.

Authors:  P Thomas; M S Dixon; S J Winterton; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

5.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells.

Authors:  H Schmid-Antomarchi; J De Weille; M Fosset; M Lazdunski
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

6.  ATP-regulated K+ channels in cardiac muscle.

Authors:  A Noma
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

7.  Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses.

Authors:  T Komaru; K G Lamping; C L Eastham; K C Dellsperger
Journal:  Circ Res       Date:  1991-10       Impact factor: 17.367

8.  Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation.

Authors:  T Aversano; P Ouyang; H Silverman
Journal:  Circ Res       Date:  1991-09       Impact factor: 17.367

9.  Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.

Authors:  G J Grover; A J D'Alonzo; C S Parham; R B Darbenzio
Journal:  J Cardiovasc Pharmacol       Date:  1995-07       Impact factor: 3.105

10.  Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries.

Authors:  K Furukawa; T Itoh; M Kajiwara; K Kitamura; H Suzuki; Y Ito; H Kuriyama
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

View more
  6 in total

1.  K+ channel opening: a new drug principle in cardiovascular medicine.

Authors:  I Gussak; F Bjerregaard
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

2.  Refractory shock following ingestion of topical minoxidil solution.

Authors:  T P Shashikala; Rajeshwar Singh; J Muthukrishnan
Journal:  Med J Armed Forces India       Date:  2016-03-29

3.  Nicorandil increased the cerebral blood flow via nitric oxide pathway and ATP-sensitive potassium channel opening in mice.

Authors:  Masakazu Kotoda; Tadahiko Ishiyama; Kazuha Mitsui; Sohei Hishiyama; Takashi Matsukawa
Journal:  J Anesth       Date:  2018-03-05       Impact factor: 2.078

4.  KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.

Authors:  Marianne Glavind-Kristensen; Vladimir Matchkov; Vibeke Brogaard Hansen; Axel Forman; Holger Nilsson; Christian Aalkjaer
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

Review 5.  Direct vasodilators and their role in hypertension management: minoxidil.

Authors:  D A Sica; T W Gehr
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Mar-Apr       Impact factor: 3.738

Review 6.  Minoxidil: an underused vasodilator for resistant or severe hypertension.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-05       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.